Bay B 5097, a new orally applicable antifungal substance with broadspectrum activity. Preliminary clinical and laboratory experiences in children.
D000284:Administration, Oral; D000935:Antifungal Agents / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D001555:Benzene Derivatives / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use; D002177:Candidiasis / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D003876:Dermatitis, Atopic / Q000188:drug therapy; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D007223:Infant; D011704:Pyelonephritis / Q000188:drug therapy*; D018805:Sepsis / Q000188:drug therapy; D014125:Toxoplasmosis, Congenital / Q000188:drug therapy
D000935:Antifungal Agents; D001555:Benzene Derivatives; D007093:Imidazoles